|
Volumn 18, Issue 9, 2010, Pages 3147-3158
|
Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels CaV1.3 and CaV1.2
|
Author keywords
Antagonism; CaV1.2 Ca+2 channel; CaV1.3 Ca+2 channel; Dihydropyridines; Dopamine neurons; FLIPR (Fluorometric imaging plate reader); Parkinson's disease; Selective antagonists
|
Indexed keywords
1,4 DIHYDROPYRIDINE;
1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLIC ACID DERIVATIVE;
CALCIUM CHANNEL CAV1.3;
CALCIUM CHANNEL CAV1.4;
CALCIUM CHANNEL L TYPE;
DIETHYL 2 METHYL 6 N PROPYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
DIETHYL 2,6 DIMETHYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
DIMETHYL 2,6 DIMETHYL 4 (2 METHYLTHIOPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
ETHYL METHOXYETHYL 2,6 DIMETHYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
ETHYL N PENTYL 2,6 DIMETHYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
ISRADIPINE;
METHYL CYANOETHYL 2,6 DIMETHYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
METHYL ETHYL 2,6 DIMETHYL 4 (2 NITROPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE;
NIFEDIPINE;
NIMODIPINE;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING SITE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TARGETING;
IC 50;
NEUROPROTECTION;
NONHUMAN;
PARKINSON DISEASE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CALCIUM CHANNEL BLOCKERS;
CALCIUM CHANNELS;
CALCIUM CHANNELS, L-TYPE;
CELL LINE;
DICARBOXYLIC ACIDS;
DIHYDROPYRIDINES;
HUMANS;
INHIBITORY CONCENTRATION 50;
MOLECULAR STRUCTURE;
NIFEDIPINE;
ANIMALIA;
MAMMALIA;
|
EID: 77951295326
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.03.038 Document Type: Article |
Times cited : (42)
|
References (25)
|